BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 37817210)

  • 1. Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype.
    Porter RL; Sun S; Flores MN; Berzolla E; You E; Phillips IE; Kc N; Desai N; Tai EC; Szabolcs A; Lang ER; Pankaj A; Raabe MJ; Thapar V; Xu KH; Nieman LT; Rabe DC; Kolin DL; Stover EH; Pepin D; Stott SL; Deshpande V; Liu JF; Solovyov A; Matulonis UA; Greenbaum BD; Ting DT
    J Clin Invest; 2022 Aug; 132(16):. PubMed ID: 35708912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-derived ovarian cancer explants: preserved viability and histopathological features in long-term agitation-based cultures.
    Abreu S; Silva F; Mendes R; Mendes TF; Teixeira M; Santo VE; Boghaert ER; Félix A; Brito C
    Sci Rep; 2020 Nov; 10(1):19462. PubMed ID: 33173111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes.
    Gou R; Hu Y; Liu O; Dong H; Gao L; Wang S; Zheng M; Li X; Lin B
    Front Oncol; 2021; 11():682461. PubMed ID: 34277429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis.
    Zhou J; Lan F; Liu M; Wang F; Ning X; Yang H; Sun H
    Front Pharmacol; 2024; 15():1350187. PubMed ID: 38327979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and senescence characteristics associated with the immune microenvironment in ovarian cancer.
    Xiong J; Fu Y; Huang J; Wang Y; Jin X; Wan X; Huang L; Huang Z
    Front Endocrinol (Lausanne); 2023; 14():1265525. PubMed ID: 38075052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of tumour microenvironment reprogramming reveals invasion in epithelial ovarian carcinoma.
    Zhang Y; Sun S; Qi Y; Dai Y; Hao Y; Xin M; Xu R; Chen H; Wu X; Liu Q; Kong C; Zhang G; Wang P; Guo Q
    J Ovarian Res; 2023 Oct; 16(1):200. PubMed ID: 37817210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
    Mao TL; Fan MH; Dlamini N; Liu CL
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition.
    Lin X; Tang X; Zheng T; Qiu J; Hua K
    J Ovarian Res; 2020 Apr; 13(1):45. PubMed ID: 32334623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 and Hypoxia Synergistically Promote EMT-Mediated Invasion in Epithelial Ovarian Cancer via the IL-6/STAT3/HIF-1
    Zhang T; Yang J; Sun Y; Song J; Gao D; Huang S; Pang A; Zhang J; Wang J; Wang Y; Li Y
    Anal Cell Pathol (Amst); 2023; 2023():8334881. PubMed ID: 36814597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
    Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
    J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes.
    Bergamini A; Luisa FM; Dellino M; Erica S; Loizzi V; Bocciolone L; Rabaiotti E; Cioffi R; Sabetta G; Cormio G; Mangili G
    Int J Gynecol Cancer; 2022 Aug; 32(8):1063-1070. PubMed ID: 35437273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hallmarks of Cancer: New Dimensions.
    Hanahan D
    Cancer Discov; 2022 Jan; 12(1):31-46. PubMed ID: 35022204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics.
    Olalekan S; Xie B; Back R; Eckart H; Basu A
    Cell Rep; 2021 May; 35(8):109165. PubMed ID: 34038734
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.